| 영문 | non-Hodgkin lymphoma | 한글 | 비호지킨 림프종 |
|---|---|---|---|
| 설명 | 림프종은 림프절에 생긴 악성 종양으로 백혈병과는 다르다. 백혈병은 골수에서 생긴 림프구성 악성종양이지만, 림프종은 림프조직에서 생긴 림프구성 악성종양이다. 크게 림프종은 2가지로 나눌 수 있는 데, 호지킨병(Hodgkin's lymphoma)과 비호지킨림프종(non-Hodgkin's lymphoma)으로 나눌 수 있다. 또한 비호지킨림프종은 여러 가지의 세포형태에 따라 나누고 있다. 이 병은 단지 림프절뿐만 아니라 지라, 골수, 이외 다른 기관을 침범함으로써 악성이며, 생명에 큰 위협을 준다. 악성림프종의 일종. 전이의 형태가 다양하여, 주위 림프절을 건너뛰어 다른 림프절로 전이하기도 한다. 또한 세포의 형태에 따라 여러 가지 종류가 있으며 대개 치료는 방사선치료와 화학요법을 복합하여 사용한다. |
||
| non-REM | non-rapid eye movement [sleep] |
|---|---|
| rem | Roentgen Equivalent Man 1 rem = 1 rad x RBE |
| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
| NANB | non-A, non-B [hepatitis] |
| NANBH | non-A, non-B hepatitis |
| REM SD | REM sleep deprivation |
|---|---|
| non-REM | Non-rapid eye movement |
| NREM | Non-REM |
| NREMS | Non-REM sleep |
| REM | Nonrapid-eye-movement |
| non-A, non-B, non-C hepatitis | Hepatitis caused by viral organisms other than hepatitis viruses A, B or C. (05 Mar 2000) |
|---|---|
| hepatitis non-A, non-B | <virology> A virus somewhat similar in size to Hepatitis A but has no antigenic cross reaction with either A or B. Many of the cases are in fact hepatitis C and this was the old term for hepatitis C. (20 Sep 2002) |
| non-A, non-B hepatitis | Hepatitis caused by two or more infectious agents not detectable by methods that reveal the presence of hepatitis viruses A and B; one cause, now called type C hepatitis has been identified; may follow blood transfusion and is often seen in chronic renal dialysis patients. Synonym: NANB hepatitis. (05 Mar 2000) |
| non-A, non-B hepatitis virus | Term used to group any of a number of viruses, other than A or B, which cause hepatitis in humans. (05 Mar 2000) |
| REM | <radiobiology> The conventional unit of dose equivalent. The dose equivalent in rem is numerically equal to the absorbed dose, D, in rad multiplied by the quality factor Q. 1 rem = 0.01 sievert. (See sievert, rad). Note: for most medical applications involving X-ray or gamma emitters, the numerical values of the absorbed dose in rad, dose equivalent in rem and exposure in R are roughly equivalent numerically. (16 Dec 1997) |
| REM behaviour disorder | A disorder characterised by lack of the atonia of voluntary muscles that normally occurs in REM sleep. (05 Mar 2000) |
| REM stage sleep | <physiology> A stage of deep sleep that is accompanied by rapid eye movement and muscle paralysis. Vivid dreams can be recalled in over 80% of patients who awake from REM stage sleep. (27 Sep 1997) |
| REM syndrome | <syndrome> A reticular erythematous dermatitis of the upper trunk, more common in women, in which there is perivascular infiltrate of lymphocytes, few plasma cells, and upper dermal deposits of mucin; worsens on exposure to ultraviolet light. Synonym: reticular erythematous mucinosis. (05 Mar 2000) |
| sleep, rem | A stage of sleep characterised by rapid movements of the eye and low voltage fast pattern eeg. It is usually associated with dreaming. (12 Dec 1998) |
| abortifacient agents, non-steroidal | Non-steroidal chemical compounds with abortifacient activity. (12 Dec 1998) |
| acute non-lymphocytic leukaemia | <haematology> A form of leukaemia which is characterised by the proliferation of immature bone marrow precursor cells in the marrow and immature white blood cells (granulocytes) in the bloodstream. Occurs primarily in adults and in infants under 1 year of age. Complications include abnormal bleeding and susceptibility to infections. Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains. Trisomy-8 is the most common cytogenetic abnormality observed, followed by monosomy-7 and monosomy-5. Approximately 8% of cases show trisomy-8, mostly in AML (M1), AM (M4) and acute monocytic leukaemia (M5). Many pre-leukaemic conditions, acute non-lymphocytic leukaemia and secondary leukemia show monosomy-7 or deletion of the long arm of chromosome 7. Treatment includes chemotherapy and/or bone marrow transplant. Acronym: ANLL Incidence: 2.5 cases per 100,000 (all ages). Origin: Gr. Haima = blood (07 Apr 1998) |
| analgesics, non-narcotic | Drugs that have principally analgesic, antipyretic, and anti-inflammatory actions. They do not bind to opioid receptors and are not classified under the controlled substances act. (12 Dec 1998) |
| anti-inflammatory agent, non-steroidal | Anti-inflammatory agents that are not steroids. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Certain nsaids also may inhibit lipoxygenase enzymes or phospholipase c or may modulate T-cell function. (ama drug evaluations annual, 1994, p 1814-5) (12 Dec 1998) |
| auctorum non | Not of authors. (09 Jan 1998) |
| cancer, lymphoma, non-hodgkin's | A lymphoma is a cancer that develops in the lymphatic system. The most common symptom of non-Hodgkin's lymphomas is a painless swelling in the lymph nodes in the neck, underarm, or groin. Non-Hodgkin's lymphomas are diagnosed with a biopsy of an enlarged lymph node. Follow-up examinations are important after lymphoma treatment. Most relapses occur in the first 2 years after therapy. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|